Say-Jong Law

Title: Say-Jong Law: Innovator in Liposome Technology

Introduction

Say-Jong Law is a notable inventor based in Dedham, MA (US). He has made significant contributions to the field of liposome technology, particularly in the area of immunoassay techniques. His innovative approach has led to the development of a unique method for functionalizing liposomes.

Latest Patents

Say-Jong Law holds a patent for the "Use of phosphotriester intermediates for preparation of functionalized." This method involves forming an analyte-functionalized liposome using a phosphotriester intermediate of a phospholipid that is derivatized with the desired analyte. The resulting liposome is functionalized on its outer surface with the analyte and carries an enzyme marker. Additionally, the method allows for the functionalization of the liposome with a ligand that acts as a leash between the analyte and the liposome. One of the notable products of this method includes a penicillin-G-functionalized liposome. He has 1 patent to his name.

Career Highlights

Say-Jong Law is associated with Collaborative Research, Inc., where he continues to advance his research and innovations. His work has been instrumental in enhancing the capabilities of liposome technology in various applications.

Collaborations

Throughout his career, Say-Jong Law has collaborated with notable colleagues, including Arthur Myles and Frank X Cole. These collaborations have contributed to the development and refinement of his innovative methods.

Conclusion

Say-Jong Law's contributions to liposome technology and immunoassay techniques highlight his role as a significant inventor in the field. His innovative methods and collaborations continue to influence advancements in this area.